Lite Strategy, Inc. Common Stock
$1.13
Market Cap
$38.45M
Shares Outstanding
34.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Dec 18, 2003
Round Lot
100
Locale
US
Day Open
$1.07
Day High
$1.15
Day Low
$1.03
Volume
1.04M
VWAP
$1.10
Prev Close
$1.04
Transactions
--
Acc. Volume
--
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
Lite Strategy, Inc. Common Stock (LITS) closed the 2026-09-18 session at $1.13, up 8.65% versus the previous close (+0.09). The stock opened at $1.07 and traded between $1.03 and $1.15 during that session. Session trading volume was 1.0M shares. The volume-weighted average price (VWAP) is $1.10.
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
Lite Strategy, Inc. Common Stock has a market capitalization of $38.4 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. LITS is listed on the XNAS exchange. The company employs approximately 4 people. Lite Strategy, Inc. Common Stock is headquartered in SAN DIEGO, CA. The recorded listing date is 2003-12-18.
On this page you can find market LITS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.